115 related articles for article (PubMed ID: 37657688)
1. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
Dutta P; Pal D; Roy A; Mandal RK; Panda CK
Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
Dutta P; Pal D; Sultana F; Mandal RK; Roy A; Panda CK
Reprod Sci; 2024 Apr; 31(4):1122-1138. PubMed ID: 38012520
[TBL] [Abstract][Full Text] [Related]
3. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
4. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
7. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
9. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
[TBL] [Abstract][Full Text] [Related]
11. Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study.
Gunes S; Agarwal A; Henkel R; Mahmutoglu AM; Sharma R; Esteves SC; Aljowair A; Emirzeoglu D; Alkhani A; Pelegrini L; Joumah A; Sabanegh E
Andrologia; 2018 Apr; 50(3):. PubMed ID: 28983945
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK
J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
14. Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.
Pal D; Samadder S; Dutta P; Roychowdhury A; Chakraborty B; Dutta S; Roy A; Mandal RK; Panda CK
Pathol Res Pract; 2023 Aug; 248():154696. PubMed ID: 37516000
[TBL] [Abstract][Full Text] [Related]
15. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair.
DuPrie ML; Palacio T; Calil FA; Kolodner RD; Putnam CD
DNA Repair (Amst); 2022 Nov; 119():103405. PubMed ID: 36122480
[TBL] [Abstract][Full Text] [Related]
16. Expressional analysis of MLH1 and MSH2 in breast cancer.
Malik SS; Masood N; Asif M; Ahmed P; Shah ZU; Khan JS
Curr Probl Cancer; 2019 Apr; 43(2):97-105. PubMed ID: 30149959
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
18. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]